A PHASE II/III RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL OF GINGER (ZINGIBER OFFICINALE) FOR NAUSEA CAUSED BY CHEMOTHERAPY FOR CANCER: A CURRENTLY ACCRUING URCC CCOP CANCER CONTROL STUDY

HICKOK, J.T., ROSCOE, J.A., & MORROW, G.R.. (2007). A PHASE II/III RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL OF GINGER (ZINGIBER OFFICINALE) FOR NAUSEA CAUSED BY CHEMOTHERAPY FOR CANCER: A CURRENTLY ACCRUING URCC CCOP CANCER CONTROL STUDY. SUPPORTIVE CANCER THERAPY, 4(4), 247-250. SID. https://sid.ir/paper/648097/en

HICKOK J.T., ROSCOE J.A., MORROW G.R.. A PHASE II/III RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL OF GINGER (ZINGIBER OFFICINALE) FOR NAUSEA CAUSED BY CHEMOTHERAPY FOR CANCER: A CURRENTLY ACCRUING URCC CCOP CANCER CONTROL STUDY. SUPPORTIVE CANCER THERAPY[Internet]. 2007;4(4):247-250. Available from: https://sid.ir/paper/648097/en

J.T. HICKOK, J.A. ROSCOE, and G.R. MORROW, “A PHASE II/III RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL OF GINGER (ZINGIBER OFFICINALE) FOR NAUSEA CAUSED BY CHEMOTHERAPY FOR CANCER: A CURRENTLY ACCRUING URCC CCOP CANCER CONTROL STUDY,” SUPPORTIVE CANCER THERAPY, vol. 4, no. 4, pp. 247–250, 2007, [Online]. Available: https://sid.ir/paper/648097/en